In this video, Emelly Rusli, the director of real-world data and analytics at Carevive, talks about their poster presentations at the upcoming ASCO Quality Care Symposium in Boston. Chief Scientific Officer, Dr. Aaron Galaznik, will share groundbreaking insights on how
Carevive’s Smart Data® is transforming treatment strategies for multiple myeloma and AML patients. The presentations will emphasize the significance of social determinants of health, cytogenetic risk, and their impressive survey compliance rate. Dr. Galaznik’s research, in partnership with Takeda, will highlight the quality of life, physical function, and treatment outcomes.
